These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 12067882)

  • 1. Short-acting neuromuscular blocking drugs allow better control of or time.
    El-Orbany M
    Can J Anaesth; 2002; 49(6):635-6. PubMed ID: 12067882
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs.
    Szocik JF; Learned DW
    J Clin Anesth; 1994; 6(5):378-82. PubMed ID: 7986509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics in anaesthesia: what are the issues?
    White PF; Watcha MF
    Eur J Anaesthesiol Suppl; 2001; 23():10-5. PubMed ID: 11766239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights in muscle relaxants.
    Leykin Y; Pellis T; Vincenti E
    Expert Rev Neurother; 2006 Dec; 6(12):1833-43. PubMed ID: 17181430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifactorial approach to understanding anesthesia selection.
    Suver JD; Arikian SR; Shannon MC; Doyle JJ; Sweeney SW
    Health Care Manage Rev; 1995; 20(3):7-15. PubMed ID: 7591755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of sedating and paralyzing the critically ill patient.
    Cheng EY
    Crit Care Clin; 1995 Oct; 11(4):1005-19. PubMed ID: 8535978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The undesirable effects of neuromuscular blocking drugs.
    Claudius C; Garvey LH; Viby-Mogensen J
    Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process analysis in the operating room.
    Andel H; Sitzwohl C; Wind L; Zimpfer M
    Acta Anaesthesiol Scand Suppl; 1997; 111():115-7. PubMed ID: 9420980
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alta Bates takes on "one of the last sacred places"--the OR and its traditions.
    Weber DO
    Strateg Healthc Excell; 1998 Jan; 11(1):7-9. PubMed ID: 10176020
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing the cost of using neuromuscular relaxants.
    Cruz JC
    Anesth Analg; 1986 Mar; 65(3):315-6. PubMed ID: 3954101
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost management in anesthesia].
    Kuhn I
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Feb; 33 Suppl 1():S36-40. PubMed ID: 9530474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Paralysis after long-term administration of neuromuscular blocking agents].
    Sugai N
    Masui; 1992 Jan; 41(1):2-10. PubMed ID: 1545497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prescribing guidelines on the use of neuromuscular blocking agents.
    Gora-Harper ML; Hessel E; Shadick D
    Am J Health Syst Pharm; 1995 Sep; 52(17):1900-4. PubMed ID: 8528853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrous-narcotic-relaxant anesthesia vs. volatile anesthesia in the adult surgical outpatient.
    Blitt C
    Contemp Anesth Pract; 1978; 1():43-54. PubMed ID: 738053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach to achieving a $950,000 cost savings from a joint anesthesia-pharmacy program.
    Durfee DD
    Hosp Pharm; 1995 Nov; 30(11):957-8, 961-3. PubMed ID: 10152916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics and anaesthesia.
    Rowe WL
    Anaesthesia; 1998 Aug; 53(8):782-8. PubMed ID: 9797523
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term pharmaceutical cost reduction using a data management system.
    McNitt JD; Bode ET; Nelson RE
    Anesth Analg; 1998 Oct; 87(4):837-42. PubMed ID: 9768779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The operating rooms: cost center management in a managed care environment.
    DeRiso B; Cantees K; Watkins WD
    Int Anesthesiol Clin; 1995; 33(4):133-50. PubMed ID: 8964622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period.
    Murphy GS
    Minerva Anestesiol; 2006 Mar; 72(3):97-109. PubMed ID: 16493386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.